-
Mashup Score: 8Validate User - 1 year(s) ago
We are sorry, but we are experiencing unusual traffic at this time. Please help us confirm that you are not a robot and we will take you to your
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 8Single-center randomized trial of T-reg graft alone vs T-reg graft plus tacrolimus for the prevention of acute GVHD - 1 year(s) ago
T-reg graft plus single-agent prophylaxis is preferred over T-reg graft alone for the prevention of acute GVHD.
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet-
T-reg graft plus single-agent prophylaxis is preferred over T-reg graft alone for the prevention of acute GVHD. https://t.co/m1WgwUH4Vg #clinicaltrialsandobservations #transplantation https://t.co/bgYrk4AOOv
-
-
Mashup Score: 40Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML - 1 year(s) ago
Maintenance treatment was safe, with low rates of infections and chronic GVHD, and minimal impact on T-cell immune reconstitution.With 2-year follow-up, Ven/Aza
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet-
Maintenance treatment was safe, with low rates of infections and chronic GVHD, and minimal impact on T-cell immune reconstitution. https://t.co/RGzjYOTK2b #clinicaltrialsandobservations #transplantation https://t.co/uvLO2nhKC7
-
-
Mashup Score: 5Myeloablative fractionated busulfan for allogeneic stem cell transplant in older patients or patients with comorbidities - 2 year(s) ago
Key Points. Myeloablative fractionated busulfan regimen results in low nonrelapse mortality without a higher relapse rate.This regimen is a viable myeloablative
Source: ashpublications.orgCategories: General Medicine News, Onc News and JournalsTweet-
This regimen is a viable myeloablative alternative for patients who receive a reduced intensity regimen because of age or comorbidity. https://t.co/eKaKpWcZL8 #clinicaltrialsandobservations #transplantation https://t.co/qjsrDLIXh5
-
Eculizumab was not associated with increased total costs after adjusting for gastrointestinal bleeding and GVHD in HR TA-TMA after allo-HCT. https://t.co/o5E7QkcoOP #clinicaltrialsandobservations #transplantation https://t.co/rLnXaVmzuK